<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30191866</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>07</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-355X</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>102</Volume>                    <Issue>2</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>International journal of radiation oncology, biology, physics</Title>                <ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>            </Journal>            <ArticleTitle>Choosing Wisely at the End of Life: Use of Shorter Courses of Palliative Radiation Therapy for Bone Metastasis.</ArticleTitle>            <Pagination>                <MedlinePgn>320-324</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0360-3016(18)30913-1</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2018.05.061</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">American Society for Radiation Choosing Wisely guidelines recommend ≤10 fractions of radiation therapy (RT) for bone metastasis, with consideration for 1 fraction in patients with a poor prognosis. The purpose of this analysis was to evaluate characteristic differences in guideline concordance to fractionation regimens in a modern cohort of older patients with a diagnosis of bone metastasis.</AbstractText>                <AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">Medicare beneficiaries aged ≥65 years treated with RT for bone metastasis from 2012 to 2015 were identified. Guideline-concordant RT fractionation was defined in the entire cohort as ≤10 fractions. Utilization of 1 fraction versus ≥2 fractions was analyzed in deceased patients. Patient demographic, disease, and facility characteristics associated with shorter fractionation were analyzed.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In 569 patients treated with RT, the median age at diagnosis was 73 years. The most common cancer types were lung (37%), genitourinary (26%), breast (15%), and gastrointestinal (10%). Among all patients, 34%, 30%, and 36% received 1 fraction, 2 to 10 fractions, and ≥11 fractions, respectively. In comparison with receipt of 1 to 10 fractions, receipt of ≥11 fractions was associated with a $1467 increase in per-patient cost to Medicare during the calendar quarter of RT. Almost two-thirds of patients who died within 30 days of RT completion were treated with &gt;1 fraction.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although guideline concordance was high overall, a large number of patients received longer courses of RT at the end of life. Strong consideration should be made for utilization of shorter courses, particularly in patients with a limited prognosis.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Wallace</LastName>                    <ForeName>Audrey S</ForeName>                    <Initials>AS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: audreywallace@uabmc.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fiveash</LastName>                    <ForeName>John B</ForeName>                    <Initials>JB</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Williams</LastName>                    <ForeName>Courtney P</ForeName>                    <Initials>CP</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kvale</LastName>                    <ForeName>Elizabeth</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Internal Medicine, University of Texas, Austin, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pisu</LastName>                    <ForeName>Maria</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Preventative Medicine, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jackson</LastName>                    <ForeName>Bradford E</ForeName>                    <Initials>BE</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Outcomes Research, JPS Health Network, Fort Worth, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rocque</LastName>                    <ForeName>Gabrielle B</ForeName>                    <Initials>GB</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>06</Month>                <Day>04</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>            <NlmUniqueID>7603616</NlmUniqueID>            <ISSNLinking>0360-3016</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>05</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>05</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30191866</ArticleId>            <ArticleId IdType="pii">S0360-3016(18)30913-1</ArticleId>            <ArticleId IdType="doi">10.1016/j.ijrobp.2018.05.061</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>